The Trump administration’s cuts to federally funded STEM research is devastating current and future innovations by NEA Higher ...
In this Healio Video Perspective from the ESCRS winter meeting, Harminder S. Dua, MD, PhD, professor of ophthalmology at the ...
A new stem cell therapy is giving hope to patients with serious cornea injuries. This breakthrough treatment could revolutionize eye health.
we would think that there's a condition in their eye that would be causing that— something again that would be maybe a corneal dystrophy, or obviously if they wear contact lenses then there ...
Approximately 4% of people aged 40 years and older have corneal endothelial disease/dystrophy (CED) affecting the back of the cornea, and corneal transplantation is the only treatment option for ...
Design has initiated dosing in a Phase 1 clinical trial in healthy volunteers in Australia to evaluate the safety and ...
Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025Dosing ...
Her laboratory is responsible for identification of genes for many different diseases, most recently for Age-Related Macular Degeneration (AMD) and Fuchs’ Endothelial Corneal Dystrophy (FECD). Her ...